Helia Group (HLI) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
13 Aug, 2026Executive summary
Statutory NPAT for 1H26 was $100.0 million, down 25% year-over-year from $133.7 million, with underlying NPAT at $106.3 million and a return on equity of 22%.
Delivered strong operational performance and renewed key customer contracts, including a new four-year agreement with ING Bank Australia, while advancing efficiency initiatives such as automation and AI.
Maintained low delinquencies and strong portfolio equity, though results were impacted by lower insurance revenue, investment gains, and the expiry of a major contract.
Surplus capital was returned to shareholders via dividends and a planned $75 million share buyback.
Strong cost management led to a reduction in operating expenses and FTEs.
Financial highlights
Statutory NPAT: $100.0 million; underlying NPAT: $106.3 million for 1H26; statutory diluted EPS: 36.2c; underlying diluted EPS: 38.5c.
Gross written premium (GWP) was $61.6 million, down 44% year-over-year, mainly due to loss of CBA new business and lower first-time buyer volumes.
Insurance revenue declined 6% year-over-year to $170.6 million.
Operating expenses reduced 16% year-over-year to $53.1 million, driven by cost reduction initiatives.
Fully franked interim ordinary dividend of 16.0cps and unfranked special dividend of 27.0cps declared.
Outlook and guidance
Full-year insurance revenue expected in the range of $330 million to $360 million.
Claims ratio for FY26 expected to remain well below through-the-cycle averages.
GWP is expected to remain impacted by the expiry of the CBA contract and government schemes.
Latest events from Helia Group
- Strong financials, board renewal, and governance focus amid CBA contract loss and policy shifts.HLI
AGM 2025 - Profit up 12%, strong premiums, prudent capital returns, and positive FY26 outlook.HLI
AGM 2026 - GWP and insurance revenue declined sharply, but claims stayed low and capital ratios remained robust.HLI
Q1 2026 TU - NPAT up 6%, GWP up 23%, and FY26 guidance signals lower revenue amid contract loss.HLI
H2 2025 - GWP up year-over-year, claims remain low, and FY25 guidance unchanged amid market headwinds.HLI
Q3 2025 TU - Statutory NPAT up 38%, GWP up 28%, but major client exits drive strategic review.HLI
H1 2025 - Underlying NPAT was AUD 107m, statutory NPAT AUD 97m, with strong capital returns and a 15c dividend.HLI
H1 2024 - GWP and NPAT surged year-over-year, but policy changes may challenge future LMI demand.HLI
Q1 2025 TU - Strong profit, robust capital returns, and higher LMI market share despite rising delinquencies.HLI
H2 2024